Senior insider sale
PRESIDENT AND CEO at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$166.7K
47.17K shares
What this filing means
AUERBACH ALAN H plans to sell 47.17K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $166.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/9/2025ACC: 0001959173-25-004519
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jul 2018
47.17K
Shares to sell
$166.7K
Approx. market value
21.58K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
7/8/2025
21.58KTotal acquired21.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/8/2025 | Restricted Stock Vesting Compensation | 21.58K | — |
| Total | 21.58K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
25.59K
Market value
$90.4K
7/8/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
21.58K
Market value
$76.3K
7/9/2025
Total
Units
47.17K
Value
$166.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/8/2025 | 25.59K | $90.4K | — | Completed |
| Planned — Approximate Date | ||||
7/9/2025 | 21.58K | $76.3K | NASDAQ | Planned |
| Total | 47.17K | $166.7K | ||